RxDoctor Payments Data
★ My doctorsLook up a doctor →

Donna Saba

Hematology & Oncology · Pleasant Hill, CANPI 1467655639

Payments from drug & device makers

$16,930in general payments, 2019–2025

Across 761 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • AstraZeneca$1K
  • Pfizer$957
  • Astellas Pharma US Inc$882
  • Amgen$869
  • Seagen Inc.$789
  • plus $11K from 54 others

What the payments were for

  • Food & beverage$15,54492%
  • Education$1,3868%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis53$1,148
AstraZeneca(2 entities)48$1,019
Pfizer56$957
Astellas Pharma US Inc30$882
Amgen30$869
Seagen Inc.34$789
Johnson & Johnson(2 entities)38$731
Takeda Pharmaceuticals U.S.A., Inc.41$618
Lilly USA, LLC26$593
Eisai Inc.22$522
Genentech USA, Inc.22$510
Merck21$496
E.r. Squibb & Sons, L.L.C.25$481
Bristol Myers Squibb31$473
GSK18$410
Incyte Corporation12$388
Gilead(2 entities)19$387
Ipsen Biopharmaceuticals, Inc1$376
Sanofi14$373
Regeneron Healthcare Solutions, Inc.11$309
AbbVie14$283
Daiichi Sankyo Inc.12$243
Epizyme, Inc.10$230
EMD Serono, Inc.11$224
Taiho Oncology, Inc.11$210
Puma Biotechnology, Inc.8$196
Karyopharm Therapeutics Inc.7$193
Pharmacyclics LLC, An Abbvie Company8$192
Array Biopharma Inc8$168
Servier Pharmaceuticals LLC8$151
Organon8$151
Beigene USA, Inc.7$145
Pharmaessentia USA Corporation5$143
Bayer6$140
Sobi, Inc5$128
Blueprint Medicines Corporation4$111
Acrotech Biopharma Inc.5$102
Stemline Therapeutics Inc.3$97
Mirati Therapeutics, Inc.5$96
AVEO Pharmaceuticals, Inc.4$96
Myovant Sciences Inc.5$91
Kyowa Kirin, Inc.4$90
Morphosys, US Inc.4$90
Rigel Pharmaceuticals, Inc.3$70
Boehringer Ingelheim3$63
Jazz Pharmaceuticals Inc.2$59
Deciphera Pharmaceuticals Inc.3$56
Bard Peripheral Vascular, Inc.1$55
Coherus Oncology, Inc.2$52
Tersera Therapeutics LLC3$51
Acceleron Pharma, Inc.2$49
Pharmacosmos Therapeutics Inc.2$47
CTI Biopharma Corp.2$43
Intuitive Surgical1$42
Tactile Systems Technology Inc2$38
Exelixis Inc.2$37
Heron Therapeutics, Inc.2$35
Global Blood Therapeutics, Inc.2$35
Springworks Therapeutics, Inc.2$28
Progenics Pharmaceuticals, Inc.1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,930 in reported general payments places this provider in the 55th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate14$227,480
EliquisApixaban47$36,417
XareltoRivaroxaban20$27,944
Ondansetron Hcl61$4,133
Lidocaine-PrilocaineLidocaine/Prilocaine64$682
Letrozole24$535
Prochlorperazine Maleate34$435
Dexamethasone18$428
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$411
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine12$243
Prednisone32$216
Omeprazole24$212
LoperamideLoperamide Hcl27$196
Hydroxyurea11$193
Acyclovir20$177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationJakafi$388$227,48014 claims
PfizerEliquis$957$36,41747 claims
Johnson & JohnsonXarelto$731$27,94420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,363 hematology & oncology providers in California.

Other hematology & oncology in Pleasant Hill

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →